chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Rash macular
Clinical narrative: Burning up all over; Feet is red and my face is all red and it is blotched; Feet is red and my face is all red and it is blotched; This is a spontaneous report from a contactable consumer or other non hcp. A patient of unspecified age and gender received bnt162b2 (BNT162B2, formulation: solution for injection, lot number: not reported, expiry date: not reported), via an unspecified route of administration on 02Mar2021 as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced burning up all over, feet is red and my face is all red and it is blotched. Patient had no side effects as soon as patient took it. Clinical outcome of the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Culture urine, Fatigue, Headache
Clinical narrative: Fever; Chills; Body ache; Headache; Fatigue; This is a spontaneous report from a contactable pharmacist (patient).  A 29-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL3247, expiration date was not reported), via intramuscular, administered in left arm on 22Jan2021 (at the age of 29-years-old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included acetaminophen (500 mg, Oral) taken for an unspecified indication from 04Jan2021, ibuprofen (400 mg, Oral) taken for an unspecified indication from 04Jan2021. The patient historical vaccine included first dose of BNT162B2 (lot number: EJ1485, expiration date was not reported) received via intramuscular, administered in left arm on 01Jan2021 12:00 for COVID-19 immunization. Patient did not receive any other medication prior to vaccination within 4 weeks. It was reported that, the patient experienced reaction after 2nd vaccine administered woke up with fever 101.3, chills, body aches, headache, fatigue. Patient fiance was covid positive last week of November 2020. We live together and she never developed symptoms. She tested negative for Covid when he tested positive and again She tested negative two weeks later. The patient underwent lab tests and procedures which included temp od 101.3 (body temperature): 101.3 on an unspecified date, Urine culture (culture urine): negative on 04Jan2021, COVID PCR (sars-cov-2 test): negative on 04Jan2021. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; Chills; Body ache; Headache; Fatigue; This is a spontaneous report from a contactable pharmacist (patient).  A 29-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL3247, expiration date was not reported), via intramuscular, administered in left arm on 22Jan2021 (at the age of 29-years-old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included acetaminophen (500 mg, Oral) taken for an unspecified indication from 04Jan2021, ibuprofen (400 mg, Oral) taken for an unspecified indication from 04Jan2021. The patient historical vaccine included first dose of BNT162B2 (lot number: EJ1485, expiration date was not reported) received via intramuscular, administered in left arm on 01Jan2021 12:00 for COVID-19 immunization. Patient did not receive any other medication prior to vaccination within 4 weeks. It was reported that, the patient experienced reaction after 2nd vaccine administered woke up with fever 101.3, chills, body aches, headache, fatigue. Patient fiance was covid positive last week of November 2020. We live together and she never developed symptoms. She tested negative for Covid when he tested positive and again She tested negative two weeks later. The patient underwent lab tests and procedures which included temp od 101.3 (body temperature): 101.3 on an unspecified date, Urine culture (culture urine): negative on 04Jan2021, COVID PCR (sars-cov-2 test): negative on 04Jan2021. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: soreness at injection site; itchiness at site; red splotch surrounding injection site; fatigue; low-grade fever; This is a spontaneous report from a contactable consumer. A 66-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6208) via an unspecified route of administration, administered in Arm Left on 08Mar2021 16:00 (age at vaccination 66-years-old) as dose 2, single for covid-19 immunisation. Medical history includes Hypothyroidism, granulomatosis with polyangiitis (GPA) in remission and Known allergies possible penicillin from an unknown date and unknown if ongoing. Concomitant medication included azathioprine (AZATHIOPRINE), losartan (LOSARTAN), levothyroxine (LEVOTHYROXINE), pyridoxine hydrochloride (VIT B6), ergocalciferol (VIT D) was taken in two weeks. The historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EI9266) via an unspecified route of administration, administered in Arm Left on 15Feb2021 16:00 (age at vaccination 66-years-old) as dose 1, single for covid-19 immunisation. On 12Mar2021, patient experienced adverse events 4-5 days post-injection of 2nd dose, continuing soreness at injection site, itchiness at site, and on day 5 a red splotch surrounding injection site Within first 24 hours, fatigue and low-grade fever but resolved within 10 hours. No treatment was received for AE. Patient has stated that she had not been diagnosed with COVID -19 prior to vaccination and not been tested since the vaccination. Outcome of the events fatigue and low-grade fever was resolved on unspecified date in Mar2021, and other events were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Haematoma, Macule
Clinical narrative: Spotting on arms and legs with some blood under skin which has disappeared since but spots still appearing; Spotting on arms and legs with some blood under skin which has disappeared since but spots still appearing; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A 72-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: EL9262), via an unspecified route of administration, administered in Arm Right on 10Feb2021 08:30 as 2nddose, single for covid-19 immunisation (Age at Vaccination was 72 years). Patient was not pregnant at time of vaccination. Historical vaccination was a 72-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: EL3247), via an unspecified route of administration, administered in Arm Right on 20Jan2021 08:30 as 1stdose, single for covid-19 immunisation. Medical history included von willebrand's disease from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing (known allergies: Soy, mango). Concomitant medication(s) included clonazepam (CLONAZEPAM) taken for an unspecified indication, start and stop date were not reported; pantoprazole (PANTOPRAZOLE) taken for an unspecified indication, start and stop date were not reported; rosuvastatin (ROSUVASTATIN) taken for an unspecified indication, start and stop date were not reported.  The patient previously took morphine and experienced drug hypersensitivity, codeine and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation.  The patient experienced spotting on arms and legs with some blood under skin which has disappeared since but spots still appearing, spotting on arms and legs with some blood under skin which has disappeared since but spots still appearing on 25Feb2021 07:00. No other vaccine in four weeks was done. Covid prior vaccination was no, covid tested post vaccination was no. Physician office visit. No treatment was received. Outcome of the events was recovered with sequelae.    No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity, Pollakiuria, Pyrexia
Clinical narrative: low grade fever; sore arm; tired; chills; frequent urination; This is a spontaneous report from a contactable consumer (patient). A 57-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: En6206, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 12Mar2021 (at the age of 57-year-old) as dose 2, single for COVID-19 immunization, at other facility. The patient medical history included interstitial cystitis. The concomitant medications for patient were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: fn 6200, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 19Feb2021 at 09:15 AM (at the age of 57-year-old) as dose 1, single for COVID-19 immunization. The patient had no known allergies. The patient received no other vaccine in four weeks and no other medications in two weeks. The patient had no COVID prior to vaccination and was not tested for COVID post vaccination. On 13Mar2021 11:00, the patient experienced low grade fever, sore arm, tired, chills, and frequent urination. No treatment was given for the events. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Swelling, Vaccination site pain
Clinical narrative: Injection site pain; I had a little swollen underneath my armpit; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced injection site pain and had a little swollen underneath my armpit on an unspecified date. The outcome of injection site pain was recovered on an unspecified date, whereas outcome of I had a little swollen underneath my armpit was recovering.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Urticaria
Clinical narrative: face swelled; upper body was covered in hives; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 39 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 11Mar2021 14:30 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included Raynaud's phenomenon from an unknown date and unknown if ongoing, milk allergy from an unknown date and unknown if ongoing. Concomitant medication(s) included propranolol (PROPRANOLOL) taken for an unspecified indication, start and stop date were not reported; gabapentin (GABAPENTIN) taken for an unspecified indication, start and stop date were not reported; quetiapine (QUETIAPINE) taken for an unspecified indication, start and stop date were not reported and vitamin D, ma taken for an unspecified indication, start and stop date were not reported. The patient experienced swelling of face on 11Mar2021 14:30 with outcome of recovered, upper body was covered in hives causing urticaria on 11Mar2021 14:30 with outcome of recovered. Therapeutic measures were taken as a result of this with Benadryl.   No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Back pain, Chest pain, Disorientation, Headache
Clinical narrative: Skin sensitivity/pain when skin was touched by clothing or pain when skin was cold; Skin sensitivity/pain when skin was touched by clothing or pain when skin was cold; Random intense pain that would come and go on foot, hand, arm, back, chest; Random intense pain that would come and go on foot, hand, arm, back, chest; Random intense pain that would come and go on foot, hand, arm, back, chest; Headache; disorientation; Stomach ache; This is a spontaneous report from a contactable other HCP (patient) reporting for herself. A 36-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: En6208), via an unspecified route of administration, administered in Left arm on 10Mar2021 16:30 at the age of 36-years-old as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. The patient had no known allergies. There were no concomitant medications. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9266), via an unspecified route of administration, administered in Left arm on 17Feb2021 05:30 PM at the age of 36-years-old as single dose for covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. The patient did not receive other medications in two weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 11Mar2021 at 06:30, the patient experienced Skin sensitivity/pain when skin was touched by clothing or pain when skin was cold. Random intense pain that would come and go on foot, hand, arm, back, chest; Headache, disorientation and Stomach ache. No treatment was received for adverse events. Adverse events resulted in none of the above. The outcome of events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperaesthesia, Pain in extremity, Pain of skin
Clinical narrative: Skin sensitivity/pain when skin was touched by clothing or pain when skin was cold; Skin sensitivity/pain when skin was touched by clothing or pain when skin was cold; Random intense pain that would come and go on foot, hand, arm, back, chest; Random intense pain that would come and go on foot, hand, arm, back, chest; Random intense pain that would come and go on foot, hand, arm, back, chest; Headache; disorientation; Stomach ache; This is a spontaneous report from a contactable other HCP (patient) reporting for herself. A 36-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: En6208), via an unspecified route of administration, administered in Left arm on 10Mar2021 16:30 at the age of 36-years-old as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. The patient had no known allergies. There were no concomitant medications. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9266), via an unspecified route of administration, administered in Left arm on 17Feb2021 05:30 PM at the age of 36-years-old as single dose for covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. The patient did not receive other medications in two weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 11Mar2021 at 06:30, the patient experienced Skin sensitivity/pain when skin was touched by clothing or pain when skin was cold. Random intense pain that would come and go on foot, hand, arm, back, chest; Headache, disorientation and Stomach ache. No treatment was received for adverse events. Adverse events resulted in none of the above. The outcome of events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Muscle spasms, Paraesthesia
Clinical narrative: my left deltoid had a spasm with the injection; my thumb, pointer and middle fingers began having intermittent numbness and tingling; my thumb, pointer and middle fingers began having intermittent numbness and tingling; ongoing intermittent, positional pain in my left shoulder radiating to the left side of my neck; This is a spontaneous report from a contactable Nurse. A 37-years-old non-pregnant female patient received second dose of bnt162b2 (BNT162B2, solution for injection; Batch/Lot Number: EN6200), dose 2 via intramuscular route of administration, administered in Arm Left on 26Feb2021 16:00 as dose 2, single (at the age of -37 years) for covid-19 immunisation at Hospital. Medical history included migraine headache and covid 19 from an unknown date and unknown if ongoing. Patient's concomitant medications were not reported. Historical vaccine included received first dose of BNT162B2 (COMIRNATY, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration, on an unspecified date for COVID-19 immunization. Prior to vaccination, the patient was diagnosed with COVID-19. Post vaccination,  patient was not tested with COVID-19. Known allergies were reported as none. No other vaccine was given in four weeks. The first injection was fine. Patient had back pain for about 24 hours after wards. On 26Feb2021 20:00 the patient experienced left deltoid had a spasm with the injection, my thumb, pointer and middle fingers began having intermittent numbness and tingling, ongoing intermittent, positional pain in my left shoulder radiating to the left side of my neck. The patient did not receive any treatment for the events. The outcome of the event was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Inappropriate schedule of product administration, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: fever; chills; muscle aches; "Start Date/Time: [Pfizer] 22Feb2021, Start Date/Time: [Pfizer] 1Mar2021; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 27-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9266), via an unspecified route of administration, administered in Arm Left on 22Feb2021 as dose 2, single for covid-19 immunisation. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing, nephrolithiasis from an unknown date and unknown if ongoing, migraine from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing peanut. Concomitant medications included atorvastatin calcium taken for an unspecified indication, start and stop date were not reported; colecalciferol (VITAMIN D) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC ALLERGY) taken for an unspecified indication, start and stop date were not reported; topiramate (TOPAMAX) taken for an unspecified indication, start and stop date were not reported; bupropion taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 03Jan2021 as dose 1, single for covid-19 immunisation. On 22Feb2021, patient experienced start date/time: [pfizer] 22feb2021, start date/time: [pfizer] 1mar2021. On 23Feb2021, the patient experienced fever, chills, muscle aches. Clinical course: After second dose, 12 hours after shot woke up in the middle of the night with fever, chills, and muscle aches. Took Advil to take fever down and went back to sleep. Woke up 6 hours later with same symptoms, took another Advil, symptoms went away and did not return. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 10Mar2021. Therapeutic measures were taken as a result of fever included advil. The outcome of the events fever, chills, and muscle aches was recovered on an unspecified date in Feb2021.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Headache, Joint swelling
Clinical narrative: feeling off all day; knee pain and swelling; knee pain and swelling; hip joint pain; tired; fall asleep just sitting down; Headache; This is a spontaneous report from a contactable consumer (patient). A 68-years-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6200) via an unspecified route of administration, administered in Arm Left on 09Mar2021 at 15:40 (at the age of 68-year-old) as dose 1, single for COVID-19 immunisation. Medical history included thyroid from an unknown date and ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID) taken for thyroid disorder from 2000 and ongoing. It was reported that from Nov2020 dose for Synthroid increased (150mcg; take once daily by mouth). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient family medical history was reported as none. Patient stated that she is scheduled for the second dose on 30Mar2021. On 09Mar2021 the patient experienced headache. On 10Mar2021 the patient experienced feeling off all day, knee pain and swelling, hip joint pain, tired, fall asleep just sitting down. It was reported that " she had her first dose of the Pfizer COVID 19 vaccine 09Mar2021 at 15:40PM in the left arm. Tuesday night she had a slight headache and she took Ibuprofen before she went to bed because the nurse said she could take it. Wednesday morning she had a slight headache again and was feeling off all day; then that afternoon all the sudden her knee buckled and she noticed the pain in her knee with swelling and hip joint muscle pain. She thought it would go away but she still has it. Adds the knee swelling in the left knee is the worst in the morning; the knee is so swollen she can't put weight on it or it buckles. She did not have this before. Mentions it is all on the left side, the left knee and the left hip. Her right side is fine. Adds she is also so tired she falls asleep just sitting down. Mentions she used to be a medic. She is scheduled for the second dose on 30Mar2021. Mentions she had read all her stuff but didn't look at the part with the risks until she just felt awful". Patient received treatment for the event headache with Ibuprofen. Outcome of the events knee pain and swelling was not recovered and other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: feeling off all day; knee pain and swelling; knee pain and swelling; hip joint pain; tired; fall asleep just sitting down; Headache; This is a spontaneous report from a contactable consumer (patient). A 68-years-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6200) via an unspecified route of administration, administered in Arm Left on 09Mar2021 at 15:40 (at the age of 68-year-old) as dose 1, single for COVID-19 immunisation. Medical history included thyroid from an unknown date and ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID) taken for thyroid disorder from 2000 and ongoing. It was reported that from Nov2020 dose for Synthroid increased (150mcg; take once daily by mouth). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient family medical history was reported as none. Patient stated that she is scheduled for the second dose on 30Mar2021. On 09Mar2021 the patient experienced headache. On 10Mar2021 the patient experienced feeling off all day, knee pain and swelling, hip joint pain, tired, fall asleep just sitting down. It was reported that " she had her first dose of the Pfizer COVID 19 vaccine 09Mar2021 at 15:40PM in the left arm. Tuesday night she had a slight headache and she took Ibuprofen before she went to bed because the nurse said she could take it. Wednesday morning she had a slight headache again and was feeling off all day; then that afternoon all the sudden her knee buckled and she noticed the pain in her knee with swelling and hip joint muscle pain. She thought it would go away but she still has it. Adds the knee swelling in the left knee is the worst in the morning; the knee is so swollen she can't put weight on it or it buckles. She did not have this before. Mentions it is all on the left side, the left knee and the left hip. Her right side is fine. Adds she is also so tired she falls asleep just sitting down. Mentions she used to be a medic. She is scheduled for the second dose on 30Mar2021. Mentions she had read all her stuff but didn't look at the part with the risks until she just felt awful". Patient received treatment for the event headache with Ibuprofen. Outcome of the events knee pain and swelling was not recovered and other events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Itchy; Bright red all around it; This is a spontaneous report from a contactable consumer or other non-health care professional. A patient of unspecified age and gender received Second dose of bnt162b2 (BNT162B2) (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, (Batch/Lot number was not reported), via an unspecified route of administration on 06Mar2021 as dose 2, single for covid-19 immunisation.The patient medical history and concomitant medications were not reported. On Mar2021, the patient experienced itchy, bright red all around it. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Balance disorder, Fatigue, Feeling abnormal, Glycosylated haemoglobin, Headache
Clinical narrative: Headache; Body Aches; Fever; Fatigue; Loss of balance; Brain fog; This is a spontaneous report from a contactable consumer (patient). An adult patient (44-45 years) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via intramuscular route of administration in the left arm on 03Mar2021 at 08:15 as dose 2, single for COVID-19 immunization. Medical history included diabetes mellitus from 02Nov2010 and ongoing, Bg well controlled, A1C 5.4 (Nov2020), anxiety from 2018 and ongoing, obsessive-compulsive disorder from 2018 and ongoing, attention deficit hyperactivity disorder from 2020 and ongoing, on medication/CBT well controlled and panic attack from an unknown date and unknown if ongoing. Patient parents were vaccinated - no side effects. They were in their 70's. Patient was an only child. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via intramuscular route of administration in the left arm on 10Feb2021 at 08:15 as dose 1, single for COVID-19 immunization and experienced headache, body aches, fever, fatigue. Concomitant medication(s) included empagliflozin (JARDIANCE) from 2012 and ongoing, metformin (METFORMIN) from 2012 and ongoing and semaglutide (OZEMPIC), injection from 2019 and ongoing, all taken for diabetes mellitus, sertraline hydrochloride (ZOLOFT) taken for anxiety, obsessive-compulsive disorder from 2018 and ongoing, propranolol taken for anxiety from 2018 and ongoing, buspirone taken for anxiety, obsessive-compulsive disorder from 2020 and ongoing, lisdexamfetamine mesilate (VYVANSE) taken for attention deficit hyperactivity disorder from 2020 and ongoing and alprazolam (XANAX) taken for panic attack from 2020 and ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient experienced headache, body aches, fever, fatigue, loss of balance and brain fog on an unspecified date in Mar2021. Patient took 2.5 days off from work, a weekend to feel normal. The patient underwent lab tests and procedures which included glycosylated haemoglobin: 5.4 % on an unspecified date in Nov2020, Bg well controlled A1C 5.4. The clinical outcome for the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Headache; Body Aches; Fever; Fatigue; Loss of balance; Brain fog; This is a spontaneous report from a contactable consumer (patient). An adult patient (44-45 years) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via intramuscular route of administration in the left arm on 03Mar2021 at 08:15 as dose 2, single for COVID-19 immunization. Medical history included diabetes mellitus from 02Nov2010 and ongoing, Bg well controlled, A1C 5.4 (Nov2020), anxiety from 2018 and ongoing, obsessive-compulsive disorder from 2018 and ongoing, attention deficit hyperactivity disorder from 2020 and ongoing, on medication/CBT well controlled and panic attack from an unknown date and unknown if ongoing. Patient parents were vaccinated - no side effects. They were in their 70's. Patient was an only child. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via intramuscular route of administration in the left arm on 10Feb2021 at 08:15 as dose 1, single for COVID-19 immunization and experienced headache, body aches, fever, fatigue. Concomitant medication(s) included empagliflozin (JARDIANCE) from 2012 and ongoing, metformin (METFORMIN) from 2012 and ongoing and semaglutide (OZEMPIC), injection from 2019 and ongoing, all taken for diabetes mellitus, sertraline hydrochloride (ZOLOFT) taken for anxiety, obsessive-compulsive disorder from 2018 and ongoing, propranolol taken for anxiety from 2018 and ongoing, buspirone taken for anxiety, obsessive-compulsive disorder from 2020 and ongoing, lisdexamfetamine mesilate (VYVANSE) taken for attention deficit hyperactivity disorder from 2020 and ongoing and alprazolam (XANAX) taken for panic attack from 2020 and ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient experienced headache, body aches, fever, fatigue, loss of balance and brain fog on an unspecified date in Mar2021. Patient took 2.5 days off from work, a weekend to feel normal. The patient underwent lab tests and procedures which included glycosylated haemoglobin: 5.4 % on an unspecified date in Nov2020, Bg well controlled A1C 5.4. The clinical outcome for the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: sore throat; low grade fever; fatigue; body aches; loss of appetite; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 25-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported, expiry date: not reported, Age at vaccination: 25-year-old) via an unspecified route of administration in Left arm on 09Mar2021 08:15 as DOSE 1, SINGLE for COVID-19 immunization. Medical history included Birth control. Concomitant medications included Albuterol HFA. On 12Mar2021, patient experienced sore throat, low grade fever, fatigue, body ache, loss of appetite. No treatment received for adverse event. Facility type vaccine was hospital. No other vaccine in four weeks. No covid present prior vaccination. Covid was not tested post vaccination. Known allergies: Cillin medications. The outcome of events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Headache, Oropharyngeal pain
Clinical narrative: sore throat; chills; cough; shortness of breath; headache; body aches; This is a spontaneous report from a contactable consumer (patient). A 67-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 10Mar2021 (at the age of 67 years old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 13Mar2021, the patient experienced sore throat, chills, cough, shortness of breath, headache and body aches. Outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: sore throat; chills; cough; shortness of breath; headache; body aches; This is a spontaneous report from a contactable consumer (patient). A 67-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 10Mar2021 (at the age of 67 years old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 13Mar2021, the patient experienced sore throat, chills, cough, shortness of breath, headache and body aches. Outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Lymphadenopathy, Pyrexia
Clinical narrative: fatigue; Swelling of lymph node region under arm and into left breast.; Temperature increase of 1.9°F above normal; headache; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional. A 46-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported), via an unspecified route of administration in left arm on 11Mar2021 at 13:45 (at the age of 46-years-old) as dose number unknown, single for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient neither diagnosed with COVID-19 prior to vaccination nor tested post vaccination. On 12Mar2021 at 04:45, the patient experienced fatigue, swelling of lymph node region under arm and into left breast, temperature increase of 1.9 degree fahrenheit above normal, headache. On 12Mar2021, the patient underwent lab tests and procedures which included body temperature result: increase (temperature increase of 1.9 degree fahrenheit above normal), body temperature: 1.9 degree Fahrenheit (temperature increase of 1.9 degree fahrenheit above normal). No treatment was received for the events. Outcome of the events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: The day after my vaccination, the rash flared up; This is a spontaneous report from a contactable other hcp. A 48-year-old non-pregnant female patient received bnt162b2 (BNT162B2, solution for injection, Lot Number: EN6204), via an unspecified route of administration, administered in Arm Left on 12Mar2021 12:00 (at the age of 48-year-old) as dose 1, single for COVID-19 immunisation. Medical history included ongoing dermatitis contact, seasonal allergy. Patient did not receive any other vaccine in four weeks. There were no concomitant medications. On 13Mar2021 08:00, the patient experienced the day after my vaccination, the rash flared up. Patient received her first Pfizer covid vaccination while she had an active case of contact dermatitis due to poison ivy. The day after vaccination, the rash flared up. Upon the flare-up, she started taking oral prednisone 20 mg with limited relief. It appears to be resolving slowly now. The outcome of the event was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# EL9265), at the age of 77, via an unspecified route of administration, on Feb 11, 2021, single dose, for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease from an unknown date and unknown if ongoing (COPD). No investigation assessment. Concomitant medication included inhaler taken for COPD. The patient experienced reddish purple rash on legs and arms on 2021. Reportedly, patient went to doctor. The outcome of the event: unknown. No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on the side going to her lower back; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Solution for injection. Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 09Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. On Mar2021, the patient experienced rash on the side going to lower back. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Miliaria, Rash, Thermal burn
Clinical narrative: Rash on my arm, even I got it on my right arm but not as much as the left and I got a little bit on my chest; I guess it is like more of the burning; looks more like a heat rash; I guess it is like more of the burning; looks more like a heat rash; I guess it is like more of the burning; looks more like a heat rash; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EN6206 and Expiration date: unknown) via an unspecified route of administration, in left arm on 07Mar2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient got this Pfizer COVID vaccine the 07Mar2021. Patient stated well, didn't get any reaction, no chills nothing like that. After about 3, 4 days, patient noticed getting like a rash on the arm. Patient got the shot on the left arm. So, it was not painful, itchy or anything but it was like even got on the right arm but not as much as the left and got a little bit on the chest (Mar2021). Patient guessed it was like more of the burning or it was nothing oozing out of it, looked more like a heat rash (Mar2021). It was stated that patient just want to know if patient should continue to get the second shot. It was reported that patient got to go back on 28Mar2021 for the 2nd dose. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Eye swelling, Lip swelling, Swelling
Clinical narrative: got a little swollen and now this morning with his chin; lips swelled up; eye got a little swollen; This is a spontaneous report from a contactable consumer or other non hcp. A 70-year-old male patient received bnt162b2 (BNT162B2, solution for injection, Lot number was unknown), via an unspecified route of administration on 12Mar2021 (at the age of 70-year-old) as dose 2, single for COVID-19 immunisation. Medical history included diabetes mellitus. Patient taking concomitant Products for Diabetes. Patient previously took bnt162b2 as dose 1 for COVID-19 immunisation. On 12Mar2021, the patient experienced lip swelling, eye swelling and on 13Mar2021, he experienced swelling. Friday night his lips swelled up last night his eye got a little swollen and now this morning with his chin. The outcome of the events was unknown. Patient took a Benadryl as a treatment drug.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Neck pain
Clinical narrative: supraclavicular lymph nodes that have popped up; severe neck pain; shoulder and clavicle pain; This is a spontaneous report from a contactable other health care professional. This health care professional reported for a consumer (patient). A 69-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. Medical history included breast cancer from 19Oct2020 (Diagnosis: breast cancer; Ibrance 75 mg) and ongoing. Concomitant medication was not reported. The patient experienced supraclavicular lymph nodes that had popped up, severe neck pain, shoulder and clavicle pain. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lacrimation increased, Nasal congestion, Nasopharyngitis, Respiratory disorder
Clinical narrative: pain on the injection site; a small lump; congested; upper respiratory issue; feeling tired; watery eyes; colds and sneezing; This is a spontaneous report from a Pfizer sponsored program. A contactable female consumer (patient) reported for herself that: A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on 06Mar2021 as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took dose 1 of bnt162b2 for COVID-19 immunisation. On an unspecified date, the patient was experienced pain on the injection site with slight redness, a small lump with a size of a dime, congested, upper respiratory issue, feeling tired, watery eyes, colds and sneezing after the second dose last 06Mar2021. "PRIVACY" was asking if it was normal to have those side effects and if can use antibiotics. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pain
Clinical narrative: pain on the injection site; a small lump; congested; upper respiratory issue; feeling tired; watery eyes; colds and sneezing; This is a spontaneous report from a Pfizer sponsored program. A contactable female consumer (patient) reported for herself that: A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on 06Mar2021 as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took dose 1 of bnt162b2 for COVID-19 immunisation. On an unspecified date, the patient was experienced pain on the injection site with slight redness, a small lump with a size of a dime, congested, upper respiratory issue, feeling tired, watery eyes, colds and sneezing after the second dose last 06Mar2021. "PRIVACY" was asking if it was normal to have those side effects and if can use antibiotics. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Got some bumps on my neck; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on 25Feb2021 as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, patient got the second shot of Pfizer COVID and on an unspecified date patient got some bumps on neck. Patient enquired that did anything to do with the shot or not; because patient never had this before. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: I had a really mild reaction; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number, Expiry date was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. Medical history included chronic pain, autoimmune disorder from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. Caller called seeking assistance with the medication flector topical system. During the call caller stated. I have chronic pain. Caller later stated on the call. I had the Pfizer COVID -19 vaccination and I just have to say I have a bad reaction to everything, and I had a really mild reaction, and I was just glad I went with Pfizer and not the others. It was great I had very minimal experience with it. I have an autoimmune disorder which is why I have the chronic pain, normally I'm on immunosuppressant medication and so I had to go off of that in order to get the vaccine and I was like oh boy it's probably gonna hit me like a ton of bricks. And you know I was pleasantly surprised that it was great. The outcome of events was unknown.   No follow-up attempts are possible. information about lot/batch number cannot be obtained.